Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Haoxi Health Technology Limited Class A ( (HAO) ) has provided an update.
Haoxi Health Technology Limited announced an extraordinary general meeting of shareholders scheduled to discuss significant proposals, including increasing the voting rights of Class B shares and expanding the authorized share capital. These changes, if approved, could enhance the company’s governance structure and financial flexibility, impacting shareholder value and market positioning.
The most recent analyst rating on (HAO) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Haoxi Health Technology Limited Class A stock, see the HAO Stock Forecast page.
Spark’s Take on HAO Stock
According to Spark, TipRanks’ AI Analyst, HAO is a Neutral.
The overall score reflects a combination of strong valuation, with the stock appearing undervalued, and moderate financial performance, highlighted by revenue growth but hampered by cash flow issues. Technical analysis indicates a lack of strong momentum, contributing to the overall risk profile.
To see Spark’s full report on HAO stock, click here.
More about Haoxi Health Technology Limited Class A
Haoxi Health Technology Limited is a company operating within the health technology sector, with its principal executive office located in Beijing, China. The company is listed on NASDAQ under the ticker HAO and is structured as a Cayman Islands exempted company with limited liability.
Average Trading Volume: 475,685
Technical Sentiment Signal: Sell
Current Market Cap: $2.78M
See more data about HAO stock on TipRanks’ Stock Analysis page.